JP Morgan Private Wealth Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,002	Closed	-$331K	–	2020
2021 Q2	$331K	Buy	2,002 +155	+8%	+$25.9K	﹤0.01%	1642
2021 Q1	$283K	Sell	1,847 -45	-2%	-$6.11K	﹤0.01%	1553
2020 Q4	$237K	Buy	+1,892	New	+$212K	﹤0.01%	1586
2020 Q1	–	Sell	-1,867	Closed	-$208K	–	1572
2019 Q4	$208K	Sell	1,867 -293	-14%	-$30.1K	﹤0.01%	1391
2019 Q3	$214K	Sell	2,160 -17	-0.8%	-$1.69K	﹤0.01%	1323
2019 Q2	$216K	Sell	2,177 -358	-14%	-$34.2K	﹤0.01%	1281
2019 Q1	$280K	Buy	+2,535	New	+$265K	﹤0.01%	1241

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

JP Morgan Private Wealth Advisors's PRAH Position: Q3 2021 in Review

JP Morgan Private Wealth Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 2,002 shares — an estimated $331K sold.

JP Morgan Private Wealth Advisors first reported a position in PRAH in Q1 2019 and held it in 7 quarters. The position peaked at $331K in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

JP Morgan Private Wealth Advisors reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
JP Morgan Private Wealth Advisors sold 2,002 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $331K.
JP Morgan Private Wealth Advisors first reported a position in PRA Health Sciences, Inc. in Q1 2019 and held it in 7 quarters.
JP Morgan Private Wealth Advisors's PRA Health Sciences, Inc. position peaked at $331K in Q2 2021.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.